Nuvectra filed a regulatory submission with the FDA for full-body MRI-conditional approval for its Algovita SCS system.
Here are three notes:
1. The Algovita SCS system is a CE marked and FDA approved for treating trunk and limb chronic pain.
2. Nuvectra hopes to have MRI-conditional approval by the end of 2017, following the 180-day review process.
3. The Algovita SCS system is Nuvectra's first commercial offering.
More articles on devices:
Jon Stryker is Michigan's top philanthropist, donating $336M in the state since 2000
Medtronic's Luann Pendy on diversity in the medical device field: 7 key thoughts
K2M reveals SAHARA AL Expandable Stabilization System: 5 takeaways
Nuvectra seeks FDA MRI-conditional approval for Algovita SCS system — 3 notes (devices, fp)